Discover the Exciting Future of Blockchain Technology at Consensus 2024: A Heartfelt Preview

Exploring the Cutting-Edge Blockchain Tech Topics at Consensus 2024 Bitcoin layer 2s, Ethereum restaking, interoperability, AI, DePIN, next-generation cryptography – these are just a few of the cutting-edge blockchain tech topics that will be discussed at CoinDesk’s Consensus 2024 conference. From May 29 to May 31, attendees in Austin, Texas will have the opportunity to…

Read More

Breaking News: Esperion Teams Up with Currax Pharmaceuticals LLC for Exciting Co-Promotion Agreement!

Esperion Announces Co-Promotion Agreement With Currax Pharmaceuticals LLC Performance-Based Agreement Provides for Currax’s Sales Representatives to Detail Esperion’s Products Reinforces Esperion’s Focus on Driving Persistent Growth By More Than Doubling Sales Team ANN ARBOR, Mich., April 19, 2023 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today announced an agreement with Currax Pharmaceuticals LLC that provides for…

Read More

“Breaking News: Enfusion Inc. Under Investigation for Securities Law Violations – What You Need to Know!”

The Schall Law Firm Investigates Enfusion, Inc. for Breaches of Fiduciary Duty LOS ANGELES, CA / ACCESS Newswire / January 25, 2025 The Schall Law Firm, a national shareholder rights litigation firm, has announced that it is currently investigating claims on behalf of investors in Enfusion, Inc. (NYSE:ENFN) for potential breaches of fiduciary duty by…

Read More

Unveiling the Future of D.R. Horton Inc.: A Comprehensive Recap of the Q4 2024 Earnings Call

D.R. Horton, Inc. (NYSE:DHI) Q4 2024 Earnings Conference Call Overview Company Participants Jessica Hansen – SVP, IR and Communications David Auld – Executive Chairman Paul Romanowski – President and CEO Michael Murray – EVP and COO Bill Wheat – EVP and CFO Conference Call Participants Stephen Kim – Evercore ISI Matthew Bouley – Barclays John…

Read More